top of page

Wedbush's Robert Driscoll joins BiotechTV for Analyst Thursdays

He discusses Vertex's acquisition of Alpine Immune Science, Bloomberg's reporting on Janux, upcoming FDA decisions on Geron and Day One, takeaways from AACR, and more.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page